Pharmaceutical Technology20d
PRGN-2012 by Precigen for Recurrent Respiratory Papillomatosis (Juvenile Laryngeal Papilloma or Laryngeal Papilloma): Likelihood of Approval
PRGN-2012 is under clinical development by Precigen and currently in Phase III for Recurrent Respiratory Papillomatosis (Juvenile Laryngeal Papilloma or Laryngeal Papilloma). According to GlobalData, ...
The Lancet20d
A high-impact study and landmark achievement in the treatment of recurrent respiratory papillomatosis
Recurrent respiratory papillomatosis (RRP) is a disease of the upper airway ... A case series of 199 patients with RRP treated at Johns Hopkins University revealed iatrogenic laryngeal injuries in 133 ...
Medindia25d
Create a Medindia Widget
Medindia offers a freely downloadable ‘Laryngeal Papillomatosis News Widget’ that can be easily installed on one or all pages of your website. Large, medium or small websites’ webmasters can ...